Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH).
Lucilla Violetta SciacquaAndrea VanzulliR Di MeoG PellegrinoR LavoratoG VitaleG CarrafielloPublished in: Technology in cancer research & treatment (2023)
Review efficacy and safety of minimally-invasive treatments for Low Urinary Tract Symptoms (LUTS) in patients affected by Benign Prostate Hyperplasia (BPH). We performed a systematic review of the literature from 1993 to 2022 leveraging original research articles, reviews, and case-studies published in peer-reviewed journals and stored in public repositories. Prostate artery embolization (PAE), transurethral needle ablation (TUNA), transurethral microwave thermotherapy (TUMT), high intensity focused ultrasound (HIFU), laser treatments and Cryoablation are valid and safe alternatives to the gold standard (surgery) in the treatment of LUTS in patients affected by BPH, with fewer undesired effects being reported.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- minimally invasive
- high intensity
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prostate cancer
- healthcare
- urinary tract
- mental health
- randomized controlled trial
- acute coronary syndrome
- meta analyses
- prognostic factors
- coronary artery disease
- emergency department
- depressive symptoms
- patient reported
- combination therapy
- mass spectrometry
- robot assisted
- physical activity
- percutaneous coronary intervention
- sleep quality
- adverse drug